For Physicians
Combining a process of 360º pressurized viscodilation and catheterization, iTrack™ is a stent-free minimally invasive glaucoma surgery (MIGS) that is clinically proven to reduce intraocular pressure in glaucoma patients. It has also been observed to reduce patient reliance on glaucoma medications.
For Patients
A simple outpatient-based procedure, iTrack™ is a minimally invasive glaucoma surgery (MIGS) that can reduce the elevated intraocular pressure associated with glaucoma. It may also free you from the financial and lifestyle burdens of glaucoma medications.
Nova Eye Medical Launches Multi-Center ‘CATALYST’ Study in Europe to Investigate Canaloplasty with the new iTrack™ Advance
Media Release iTrack
11 Aug, 2022
Nova Eye Medical Announces Global Data Registry to Support Role of Canaloplasty for Glaucoma
Media Release iTrack
4 Aug, 2022
Sales Performance Glaucoma Surgical Devices Segment
ASX Announcement General iTrack Molteno3
8 Jul, 2022
For Physicians
Combining a process of 360º pressurized viscodilation and catheterization, iTrack™ is a stent-free minimally invasive glaucoma surgery (MIGS) that is clinically proven to reduce intraocular pressure in glaucoma patients. It has also been observed to reduce patient reliance on glaucoma medications.
For Patients
A simple outpatient-based procedure, iTrack™ is a minimally invasive glaucoma surgery (MIGS) that can reduce the elevated intraocular pressure associated with glaucoma. It may also free you from the financial and lifestyle burdens of glaucoma medications.
Latest News
See allNova Eye Medical Launches Multi-Center ‘CATALYST’ Study in Europe to Investigate Canaloplasty with the new iTrack™ Advance
Media Release iTrack
11 Aug, 2022
Nova Eye Medical Announces Global Data Registry to Support Role of Canaloplasty for Glaucoma
Media Release iTrack
4 Aug, 2022
Sales Performance Glaucoma Surgical Devices Segment
ASX Announcement General iTrack Molteno3
8 Jul, 2022